Tildrakizumab Promising for Psoriasis in Patients with PsA

New research shows tildrakizumab may significantly improve psoriasis in patients with active psoriatic arthritis...

Source: The Rheumatologist - December 2, 2019 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: DMARDs & Immunosuppressives Drug Updates 2019 ACR/ARP Annual Meeting Psoriasis psoriatic arthritis tildrakizumab Source Type: research